In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug
Xinan Shi(Wuhan University), Marie C.M. Lin(Zhengzhou University)
Cited by 85
Related Papers
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
|Clinical Cancer Research|2011|338
Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma
|Molecular Medicine Reports|2015|63
The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer
|International Journal of Biological Sciences|2019|35
Adenosine diphosphate‐ribosylation factor 6 is required for epidermal growth factor‐induced glioblastoma cell proliferation
|Cancer|2009|34
Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells
|Scientific Reports|2017|21